Table 3 Resolution of symptoms and key subclinical indicators by day 5 of treatment period.

From: High-dose multi-strain Bacillus probiotics enhance treatment and reduce antibiotic usage in children with persistent diarrhea through immune and microbiota modulation

Characteristic

Control group

(N = 49)

Dia30 group

(N = 48)

OR

95% CI

p value

Free of all symptoms n (%)

10 (20.41)

34 (70.83)

9.47

3.75–22.5

< 0.0001b

Stools a day of < 3 n (%)

11 (22.45)

34 (70.83)

8.39

3.41–19.67

< 0.0001b

Absence of fecal mucus n (%)

15 (30.61)

36 (75.0)

6.80

2.86–16.87

< 0.0001b

Diaper stool types 2–3 n (%)

25 (51.02)

38 (79.17)

3.65

1.5–9.31

0.0037b

Erythrocyte negative and trace n (%)

44 (89.80)

47 (97.92)

5.34

0.67–64.08

0.2041a

Leukocyte negative and trace n (%)

43 (87.76)

48 (100)

14.49

0.79–264.9

0.0266a

  1. aFisher’s Exact test; bChi-Square test.